Reply to: Uric Acid and Contrast-Induced Nephropathy: Diagnostic Marker,Therapeutic Target,or Innocent Bystander?

Abstract

Get full access to this article

View all access options for this article.

References

Canpolat

Coteli

Kivrak

. Uric acid and contrast-induced nephropathy: diagnostic marker, therapeutic target, or innocent bystander? Angiology. 2017;68(7):648–649.

Mendi

Afsar

Oksuz

. Uric acid is a useful tool to predict contrast-induced nephropathy. Angiology. 2017;68(7):627–632.

Kanbay

Solak

Afsar

. Serum uric acid and risk for acute kidney injury following contrast: an evaluation of epidemiology, clinical trials, and potential mechanisms. Angiology. 2017;68(2):132–144.

Erol

Tekin

Katircibasi

. Efficacy of allopurinol pretreatment for prevention of contrast-induced nephropathy: a randomized controlled trial. Int J Cardiol. 2013;167(4):1396–1399.

Kumar

Bhawani

Kumari

Murthy

Lalwani

N R

. Comparative study of renal protective effects of allopurinol and N-acetyl-cysteine on contrast induced nephropathy in patients undergoing cardiac catheterization. J Clin Diagnostic Res. 2015;8(12):HC03–HC07.

Hahn

Kanbay

Lanaspa

Johnson

Ejaz

. Serum uric acid and acute kidney injury: a mini review [published online September 24, 2016.]. J Adv Res. DOI: https://doi.org/10.1016/j.jare.2016.09.006.